FDA Cell therapies and tissue-based products: a public workshop on generating scientific evidence to facilitate development (from Catapult’s regulatory round-up for December 2024)
The FDA’s CBER OTP is hosting a virtual scientific public workshop on 25th February 2025, titled “Cell Therapies and Tissue-based Products: A Public Workshop on Generating Scientific Evidence to Facilitate Development.” The purpose of the workshop is to identify and discuss the current state of the science, development, and regulation for cellular therapies and tissue-based products. Please find further information including how to register here.
Published on the 9th of January 2025. Read the entire Regulatory Round-up – December 2024.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (12 février 2025). FDA Cell therapies and tissue-based products: a public workshop on generating scientific evidence to facilitate development (from Catapult’s regulatory round-up for December 2024). ELSIBI. Consulté le 19 janvier 2026 à l’adresse https://doi.org/10.58079/13ay4





